Lansoprazole Aurobindo (Lansoprazole)

Lansoprazole belongs to the proton pump inhibitor class. It binds irreversibly to the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This binding blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity.

The specific dose and treatment duration are determined by the prescribing clinician based on the patient’s diagnosis, severity of disease, and individual response. Healthcare professionals tailor the regimen to achieve optimal acid control while minimizing potential risks.

Safety data for Lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the medication with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lansoprazole, like other proton pump inhibitors (e.g., omeprazole, esomeprazole), provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with some PPIs, Lansoprazole has a similar efficacy profile but may differ slightly in metabolism pathways, which can influence drug‑interaction potential.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Protect it from excess moisture and direct sunlight. Do not refrigerate or freeze unless the label specifically indicates otherwise.

Lansoprazole Aurobindo is taken orally, usually as a whole tablet or capsule. It should be swallowed with a glass of water, preferably before a meal, unless the prescribing information advises otherwise.

Serious adverse events, though uncommon, include severe allergic reactions (anaphylaxis), significant low magnesium levels that can cause muscle weakness or cardiac arrhythmias, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, persistent diarrhea, or muscle cramps.

Individuals with a known hypersensitivity to lansoprazole or any component of the formulation should avoid the product. Caution is also advised for patients with severe liver disease, as metabolism may be impaired. The prescribing clinician will evaluate contraindications before initiating therapy.